Need a Health professional?

Shreyaansh Lifesciences, Jaipur. India

Polatuzumab Vedotin-piiq Injection 140 mg
Polatuzumab Vedotin-piiq Injection interferes with the growth of cancer cells, which are then destroyed by the body. This medicine is to be given only by or under the direct supervision of your doctor.
Polatuzumab Vedotin-piiq Injection was approved for medical use in the United States in 2019. It is on the World Health Organization’s List of Essential Medicines.
Polatuzumab Vedotin-piiq Injection Available Price In India UK Saudi Arabia

Polatuzumab Vedotin-piiq Injection

  • Generic Brand Available – Polivy
  • API – Polatuzumab Vedotin-piiq
  • Packaging – Glass Bottle
  • Strength – 140 mg per vial

What is Polatuzumab Vedotin-piiq Injection used for?

  • Polatuzumab vedotin-piiq is approved to treat: Diffuse large B-cell lymphoma in adults whose cancer has relapsed or has not gotten better after at least two other therapies. It is used with bendamustine hydrochloride and rituximab.
    Disclaimer

    All Trademarks and Brands that appear on website belong to their respective owners and Ikris Pharma Network does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Iron Sucrose is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.

    Get Access To Polatuzumab Vedotin-piiq Injection 140 mg

    Shreyaansh Lifesciences, Jaipur. India

    Shreyaansh Lifesciences is registered in Jaipur, India. Registration Number : 08AEEFS9350K1ZI under GST Act. 
    Branch Offices in India : Jaipur | New Delhi

    SF-72-73 2ND FLOOR, Jaipur Electronic Market, Ridhi Sidhi Choraha, Jaipur, Rajasthan, 302018.

    +91 99292 77766

    Facts of Medicines

    Polatuzumab Vedotin-piiq Injection 140 mg

    DRUG INTERACTIONS

    Concomitant use of strong CYP3A inhibitors or inducers has the potential to affect the exposure to unconjugated monomethyl auristatin E (MMAE).

     DOSAGE

     The recommended dose of POLIVY is 1.8 mg/kg as an intravenous infusion over 90 minutes every 21 days for 6 cycles in combination with bendamustine and a rituximab product. Subsequent infusions may be administered over 30 minutes if the previous infusion is tolerated. 
    • Premedicate with an antihistamine and antipyretic before POLIVY. 

    SIDE EFFECT

    Nausea, Fever, Decreased appetite, Infections,Low blood cell counts (platelets, red blood cells, white blood cells)
    Nerve problems in arms and legs, Tiredness or lack of energy, Diarrhea,

    WARNINGS AND PRECAUTIONS

    • This drug may make you dizzy. Alcohol or marijuana (cannabis) can make you more dizzy. Do not drive, use machinery, or do anything that needs alertness until you can do it safely. Limit alcoholic beverages. Talk to your doctor if you are using marijuana (cannabis).

    •  Before having surgery, tell your doctor or dentist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products).

      FAQs – Medicine Questions

      Polatuzumab Vedotin-piiq Injection 140 mg
      What is Polatuzumab vedotin-PIIQ?
      Polatuzumab vedotin-piiq is approved to treat: Diffuse large B-cell lymphoma in adults whose cancer has relapsed or has not gotten better after at least two other therapies. It is used with bendamustine hydrochloride and rituximab.
      Is Polatuzumab vedotin chemotherapy?
      Polatuzumab vedotin is a monoclonal antibody, called polatuzumab, linked to a chemotherapy drug, called vedotin. Polatuzumab is a form of targeted therapy because it attaches to specific receptors on the surface of cancer cells, known as CD79B receptors, and delivers vedotin to kill them.
      How does Polatuzumab vedotin work?
      Polatuzumab Vedotin-piiq interferes with the growth of cancer cells, which are then destroyed by the body. This medicine is to be given only by or under the direct supervision of your doctor.
      Where can I buy Polatuzumab Vedotin-piiq Injection?

      You can buy Polatuzumab Vedotin-piiq Injection from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.

      The buyer should check the existing law in their home country before importing the product.

      What is the procedure to buy Polatuzumab Vedotin-piiq Injection?

      Patients can simply fill the order form or can send mail at info@treatmentoptions4u.com. Patients can also send WhatsApp messages to +91 99292 77766 / 98738 10020   We will reply ASAP with the details of the Polatuzumab Vedotin-piiq Injection price as well as procurement procedure.

      Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.

      Is Polatuzumab FDA approved?
      The FDA has approved the CD79b-directed antibody drug conjugate polatuzumab vedotin-piiq, in combination with bendamustine and rituximab (BR), to treat adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who have received at least two prior therapies.

      NEWS / UPDATES